Code | 6729E | ||||||||||
MA number | 63/0188/17-S | ||||||||||
Product Form: | sol ijf 5x100 mg/10 ml (amp.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | hameln pharma gmbh, Germany | ||||||||||
Therapeutic Class: | 63 - MYORELAXANTIA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Rocuronium bromide hameln 10mg_ml inj_ inf roztok_10_2022.pdf |
SPC: | SPC_Rocuronium bromide hameln 10mg_ml inj_ inf roztok_10_2022.pdf |
Safety feature | Yes |
Data update: | 27.06.2024 |